133 related articles for article (PubMed ID: 7942730)
1. Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis.
Spivey JR; Jorgensen RA; Gores GJ; Lindor KD
Am J Gastroenterol; 1994 Nov; 89(11):2028-32. PubMed ID: 7942730
[TBL] [Abstract][Full Text] [Related]
2. [Met-enkephalin plasma concentration and content in liver tissue in patients with primary biliary cirrhosis].
Owczarek D; Garlicka M; Pierzchała-Koziec K; Skulina D; Szulewski P
Przegl Lek; 2003; 60(7):461-6. PubMed ID: 14750419
[TBL] [Abstract][Full Text] [Related]
3. Cholestatic liver diseases and health-related quality of life.
Younossi ZM; Kiwi ML; Boparai N; Price LL; Guyatt G
Am J Gastroenterol; 2000 Feb; 95(2):497-502. PubMed ID: 10685757
[TBL] [Abstract][Full Text] [Related]
4. Natural history of pruritus in primary biliary cirrhosis.
Talwalkar JA; Souto E; Jorgensen RA; Lindor KD
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):297-302. PubMed ID: 15017671
[TBL] [Abstract][Full Text] [Related]
5. Endogenous opioid-mediated antinociception in cholestatic mice is peripherally, not centrally, mediated.
Nelson L; Vergnolle N; D'Mello C; Chapman K; Le T; Swain MG
J Hepatol; 2006 Jun; 44(6):1141-9. PubMed ID: 16466825
[TBL] [Abstract][Full Text] [Related]
6. Pruritus and fatigue in primary biliary cirrhosis.
Bergasa NV; Mehlman JK; Jones EA
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):643-55. PubMed ID: 10976020
[TBL] [Abstract][Full Text] [Related]
7. Plasma metallothionein concentration in patients with liver disorders: special emphasis on the relation with primary biliary cirrhosis.
Mulder TP; Janssens AR; Verspaget HW; Lamers CB
Hepatology; 1991 Dec; 14(6):1008-12. PubMed ID: 1959846
[TBL] [Abstract][Full Text] [Related]
8. Do increased catecholamines and plasma methionine enkephalin in cirrhosis promote bleeding oesophageal varices?
Thornton JR; Dean HG; Losowsky MS
Q J Med; 1988 Jul; 68(255):541-51. PubMed ID: 3266978
[TBL] [Abstract][Full Text] [Related]
9. Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis.
Floreani A; Variola A; Niro G; Premoli A; Baldo V; Gambino R; Musso G; Cassader M; Bo S; Ferrara F; Caroli D; Rizzotto ER; Durazzo M
Am J Gastroenterol; 2008 Aug; 103(8):1959-65. PubMed ID: 18564121
[TBL] [Abstract][Full Text] [Related]
10. Pruritus in primary biliary cirrhosis: pathogenesis and therapy.
Bergasa NV
Clin Liver Dis; 2008 May; 12(2):385-406; x. PubMed ID: 18456187
[TBL] [Abstract][Full Text] [Related]
11. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis.
Batts KP; Jorgensen RA; Dickson ER; Lindor KD
Am J Gastroenterol; 1996 Nov; 91(11):2314-7. PubMed ID: 8931409
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Babatin MA; Sanai FM; Swain MG
Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
[TBL] [Abstract][Full Text] [Related]
13. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
[TBL] [Abstract][Full Text] [Related]
14. Met-enkephalin in the liver as a marker of hepatocellular damage in chronic viral hepatitis type B and C.
Cieśla A; Mach T; Pierzchała-Koziec K; Skwara P; Szczepański W
Adv Med Sci; 2006; 51():261-4. PubMed ID: 17357322
[TBL] [Abstract][Full Text] [Related]
15. Opioid peptides and primary biliary cirrhosis.
Thornton JR; Losowsky MS
BMJ; 1988 Dec; 297(6662):1501-4. PubMed ID: 3147046
[TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor alpha and cellular proliferation in primary biliary cirrhosis.
Floreani A; Infantolino D; Biasin R; Della Rovere GR; Biagini MR; Melis A; Chiaramonte M
Ital J Gastroenterol Hepatol; 1999; 31(1):56-60. PubMed ID: 10091104
[TBL] [Abstract][Full Text] [Related]
17. [Activity of neutral endopeptidase in serum of patients with primary biliary cirrhosis].
Horvát-Karajz K; Csepregi A; Nemesánszky E; Tulassay Z; Selmeci L; Szalay F
Orv Hetil; 2000 Apr; 141(18):963-5. PubMed ID: 10832380
[TBL] [Abstract][Full Text] [Related]
18. A study of the mu opioid receptor gene polymorphism A118G in patients with primary biliary cirrhosis with and without pruritus.
Wei LX; Floreani A; Variola A; El Younis C; Bergasa NV
Acta Derm Venereol; 2008; 88(4):323-6. PubMed ID: 18709298
[TBL] [Abstract][Full Text] [Related]
19. Alterations in hypothalamic mu-opiate receptor-mediated responses but not methionine enkephalin or proenkephalin messenger RNA levels in rats with acute cholestasis.
Swain MG
Hepatology; 1994 Sep; 20(3):700-5. PubMed ID: 8076927
[TBL] [Abstract][Full Text] [Related]
20. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.
Guañabens N; Parés A; Ros I; Caballería L; Pons F; Vidal S; Monegal A; Peris P; Rodés J
J Hepatol; 2005 Apr; 42(4):573-7. PubMed ID: 15763344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
